Trials / Recruiting
RecruitingNCT06455904
Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Centre Paul Strauss · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The association of anthracyclines (ANT) and paclitaxel (Tax) is one of the main treatments used in breast cancer. These treatments are known to induce severe side effects such as a decrease in overall exercise capacity (physical condition) in response to muscle and cardiorespiratory alterations. If exercise may be an effective preventive strategy, it seems important to prescribe the most efficient exercise modality. Among them, concentric cycling (i.e., classic cycling) can significantly induce metabolic stimulus, which is needed for maintaining exercise capacity. The PROTECT-07 study aims to demonstrate the superiority of a training program based on concentric cycling during chemotherapy compared to standard treatment. The duration of the training program is 15 weeks with one session per week.
Detailed description
There will be two groups of patients after drawing lots using a process called randomization. The probability is one in two of being in the group participating in the training program, the other group following the standard treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Training sessions | The training program will be performed during 15 weeks, with one session per week. |
Timeline
- Start date
- 2024-05-30
- Primary completion
- 2027-01-13
- Completion
- 2027-01-13
- First posted
- 2024-06-12
- Last updated
- 2026-02-02
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06455904. Inclusion in this directory is not an endorsement.